Oaktree Acquisition Corp. III Life Sciences SEC EDGAR Filings (CIK 0002029769)

SEC EDGAR filings, ownership reports, and insider transactions for Oaktree Acquisition Corp. III Life Sciences.

Symbol
OACC, OACCU, OACCW on Nasdaq
Industry
Blank Checks (Office Of Real Estate & Construction)
Business address
333 South Grand Avenue, 28 Th Floor, Los Angeles, CA, 90071
State of incorporation
Cayman Islands
Fiscal year end
31 December
⭐ Add to watchlist ⭐
Get insider transactions for this issuer
Oaktree Acquisition Corp. III Life Sciences has filed 50 SEC EDGAR filings since 07 Aug 2024

Latest Filings

Recent SEC filings for Oaktree Acquisition Corp. III Life Sciences including 10-Q, 3, 8-K and more.

Form type Document Filing Description Filing date Reporting date File number(s)
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 13 Nov 2025 30 Sep 2025 001-42383
3 Open 3 document View SEC filing for 3 3 29 Oct 2025 29 Oct 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 29 Oct 2025 29 Oct 2025 001-42383
3 Open 3 document View SEC filing for 3 3 22 Oct 2025 17 Oct 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 17 Oct 2025 17 Oct 2025 001-42383
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 12 Aug 2025 005-94673
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 12 Aug 2025 30 Jun 2025 001-42383
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 15 Jul 2025 005-94673
3 Open 3 document View SEC filing for 3 3 16 Jun 2025 03 Jun 2025
8-K Open 8-K document | Open XBRL data View SEC filing for 8-K 8-K 06 Jun 2025 03 Jun 2025 001-42383
10-Q Open 10-Q document | Open XBRL data View SEC filing for 10-Q 10-Q 14 May 2025 31 Mar 2025 001-42383
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 14 May 2025 005-94673
SCHEDULE 13G/A Open SCHEDULE 13G/A document View SEC filing for SCHEDULE 13G/A 14 May 2025 005-94673
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 13 May 2025 005-94673
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 09 May 2025 005-94673
10-K Open 10-K document View SEC filing for 10-K 10-K 27 Mar 2025 31 Dec 2024 001-42383
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 14 Feb 2025 005-94673
SCHEDULE 13G Open SCHEDULE 13G document View SEC filing for SCHEDULE 13G 12 Feb 2025 005-94673
8-K Open 8-K document View SEC filing for 8-K 8-K 07 Jan 2025 06 Jan 2025 001-42383
8-K Open 8-K document View SEC filing for 8-K 8-K 11 Dec 2024 11 Dec 2024 001-42383
SC 13G Open SC 13G document View SEC filing for SC 13G AQR CAPITAL MANAGEMENT LLC 07 Nov 2024 005-94673
8-K Open 8-K document View SEC filing for 8-K 8-K 05 Nov 2024 30 Oct 2024 001-42383
4 Open 4 document View SEC filing for 4 4 31 Oct 2024 30 Oct 2024
8-K Open 8-K document View SEC filing for 8-K 8-K 31 Oct 2024 25 Oct 2024 001-42383
SC 13G Open SC 13G document View SEC filing for SC 13G 30 Oct 2024 005-94673
8-K Open 8-K document View SEC filing for 8-K 8-K 25 Oct 2024 23 Oct 2024 001-42383
424B4 Open 424B4 document View SEC filing for 424B4 424B4 24 Oct 2024 333-282508
CERT Open CERT document View SEC filing for CERT 24 Oct 2024 001-42383
EFFECT Open EFFECT document View SEC filing for EFFECT 23 Oct 2024 333-282508
3 Open 3 document View SEC filing for 3 3 23 Oct 2024 23 Oct 2024
3 Open 3 document View SEC filing for 3 3 23 Oct 2024 23 Oct 2024
3 Open 3 document View SEC filing for 3 3 23 Oct 2024 23 Oct 2024
3 Open 3 document View SEC filing for 3 3 23 Oct 2024 23 Oct 2024
3 Open 3 document View SEC filing for 3 3 23 Oct 2024 23 Oct 2024
3 Open 3 document View SEC filing for 3 3 23 Oct 2024 23 Oct 2024
3 Open 3 document View SEC filing for 3 3 23 Oct 2024 23 Oct 2024
3 Open 3 document View SEC filing for 3 3 23 Oct 2024 23 Oct 2024
8-A12B Open 8-A12B document View SEC filing for 8-A12B 8-A12B 23 Oct 2024 001-42383
CORRESP Open CORRESP document View SEC filing for CORRESP 21 Oct 2024
CORRESP Open CORRESP document View SEC filing for CORRESP 21 Oct 2024
CORRESP Open CORRESP document View SEC filing for CORRESP 18 Oct 2024
S-1/A Open S-1/A document View SEC filing for S-1/A S-1/A 18 Oct 2024 333-282508
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 18 Oct 2024 377-07367
CORRESP Open CORRESP document View SEC filing for CORRESP 04 Oct 2024
S-1 Open S-1 document View SEC filing for S-1 S-1 04 Oct 2024 333-282508
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 01 Oct 2024 377-07367
DRSLTR Open DRSLTR document View SEC filing for DRSLTR 13 Sep 2024
DRS/A Open DRS/A document View SEC filing for DRS/A 13 Sep 2024 377-07367
UPLOAD Open UPLOAD document View SEC filing for UPLOAD 05 Sep 2024 377-07367
DRS Open DRS document View SEC filing for DRS 07 Aug 2024 377-07367

About this filer

Oaktree Acquisition Corp. III Life Sciences files with the SEC under CIK 0002029769. This page aggregates EDGAR filings and related ownership activity.

Industry: Blank Checks.

See insider transactions for this issuer.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages